![](/img/cover-not-exists.png)
Maintenance of low disease activity and remission with etanercept–disease-modifying antirheumatic drug (DMARD) combination therapy compared with treatment with DMARDs alone in Latin American patients with active rheumatoid arthritis
Zerbini, Cristiano A.F., Abud-Mendoza, Carlos, Mendez-Patarroyo, Paul, De Angelo Andrade, Mauricio, Pedersen, Ron, Vlahos, Bonnie, Borlenghi, Cecilia ElenaVolume:
97
Journal:
Medicine
DOI:
10.1097/md.0000000000011989
Date:
September, 2018
File:
PDF, 339 KB
2018